Vigilare Wealth Management Atreca, Inc. Transaction History

Vigilare Wealth Management

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 07, 2022	SELL	$2.87 - $6.29 $54,386 - $119,195	-18,950 Closed	0 $0
Q3 2021 Oct 19, 2021	SELL	$4.91 - $9.07 $69,722 - $128,794	-14,200 Reduced 42.84%	18,950 $118,000
Q2 2021 Jul 16, 2021	BUY	$7.82 - $13.8 $86,802 - $153,180	11,100 Added 50.34%	33,150 $282,000
Q1 2021 Apr 29, 2021	BUY	$13.0 - $19.34 $27,560 - $41,000	2,120 Added 10.64%	22,050 $338,000
Q4 2020 Jan 14, 2021	BUY	$13.03 - $17.09 $17,720 - $23,242	1,360 Added 7.32%	19,930 $322,000

Q3 2020 Oct 15, 2020	BUY	$12.67 - $23.19 $108,328 - $198,274	8,550 Added 85.33%	18,570 $259,000
Q2 2020 Jul 20, 2020	BUY	$12.52 - $23.45 $125,450 - $234,969	10,020 New	10,020 $213,000

1.04M

Ticker BCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,876,000
Description
Atreca, Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody-based immunotherapeutics to treat a range of solid tumor types. Its lead product candidate is ATRC-101, a monoclonal antibody with a novel mechanism of action and target derived from an antibody identified using its discovery platform. The company's ATRC-10...

Get notified when there are updates to the investment portfolio of Vigilare Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Vigilare Wealth Management with notifications on news.